Corteria Pharmaceuticals Funding: $71M Raised, Series A
Corteria Pharmaceuticals is based in Paris, France. It has raised $71M in total funding. Latest round: Series A.
Corteria Pharmaceuticals funding overview
Corteria Pharmaceuticals is based in Paris, France. Corteria Pharmaceuticals has raised $71M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2023. The round record for Corteria Pharmaceuticals runs through 2023; nothing later has been disclosed. Investors on record include OrbiMed, Jeito Capital, Kurma Partners, Fountain Healthcare Partners, V-Bio Ventures, Invivo Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
Corteria Pharmaceuticals at a glance
Total raised
$71M
Latest round
Series A
Latest round date
September 2023
Headquarters
Paris, France
Notable investors
OrbiMed, Jeito Capital, Kurma Partners, Fountain Healthcare Partners, V-Bio Ventures, Invivo Capital, Omnes Capital
Frequently asked about Corteria Pharmaceuticals funding
How much has Corteria Pharmaceuticals raised?
Corteria Pharmaceuticals has raised $71M in total disclosed funding across the rounds on record.
Who has invested in Corteria Pharmaceuticals?
OrbiMed, Jeito Capital, Kurma Partners, Fountain Healthcare Partners, V-Bio Ventures, Invivo Capital are named among the investors backing Corteria Pharmaceuticals.
What was the latest Corteria Pharmaceuticals funding round?
The most recent disclosed round is a Series A, announced in September 2023.
Where is Corteria Pharmaceuticals based?
Corteria Pharmaceuticals is based in Paris, France.
When did Corteria Pharmaceuticals last raise?
The last disclosed Corteria Pharmaceuticals round closed in September 2023 at Series A.
Totals shown for Corteria Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Paris and the investors behind them below.
Companies related to Corteria Pharmaceuticals (36)
